These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5849152)

  • 21. Aspiration biopsy of bone. Use in the management of metastatic gynecologic malignancy.
    Llorens AS; Graham RM
    Obstet Gynecol; 1968 May; 31(5):708-13. PubMed ID: 5646403
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis and treatment of patients with osteoporosis in the post-climacteric period].
    Kotova SM; Alesov VZ; Karlova NA; Rokhlin GD; Lebedeva NA
    Vrach Delo; 1985 Mar; (3):114-8. PubMed ID: 4013149
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M; Yonese J; Fukui I; Ogata E
    J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Attempt at direct surgical approach in certain osseous metastases].
    Auquier L; Delrieu F
    Rev Rhum Mal Osteoartic; 1969 Dec; 36(12):681-7. PubMed ID: 5380934
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrine treatment of gynecologic neoplasms].
    Maass H
    Fortschr Med; 1980 Oct; 98(40):1551-3. PubMed ID: 7461551
    [No Abstract]   [Full Text] [Related]  

  • 26. [Postclimacteric spondylopathy].
    Ioffe AZ; Nekachalov VV; Bystrova ZK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):504-9. PubMed ID: 7269949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis.
    Nazarian A; von Stechow D; Zurakowski D; Müller R; Snyder BD
    Calcif Tissue Int; 2008 Dec; 83(6):368-79. PubMed ID: 18946628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiographic manifestations of osseous metastases from renal cell carcinoma.
    Gooding CA; O'Connor JF; Dealy JB
    Vasc Dis; 1966 Jun; 3(3):208-20. PubMed ID: 5939442
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancer.
    Lüfter D; Richter A; Günther S; Flath B; Akrivakis C; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2000; 20(6D):5099-105. PubMed ID: 11326676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sterolibrin therapy of endocrine deficiencies during induced climacteric in oncology].
    Dvorák V; Stára B; Cepelák J; Stĕrba R
    Zentralbl Gynakol; 1972 Jul; 94(30):960-4. PubMed ID: 5081050
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of advanced mammary carcinomas with high-dosed cytostatics].
    Boeckl O; Heitz N; Wasl H; Karrer K; Mannheimer E
    Munch Med Wochenschr; 1965 Oct; 107(43):2114-8. PubMed ID: 5899028
    [No Abstract]   [Full Text] [Related]  

  • 32. [Macrophage colony-stimulating factor for treatment of prostatic cancer with bone metastases].
    Hayashi T; Kakehi R
    Hinyokika Kiyo; 1993 Jan; 39(1):101-5. PubMed ID: 8460579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reflections apropos of a surprising survival in a patient with pulmonary and osseous metastases of thyroidal origin].
    Le van Truoc V
    J Radiol Electrol Med Nucl; 1967; 48(8):507-8. PubMed ID: 6064186
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of cancer of the gallbladder with multiple osseous metastases].
    Commandre F; Dalbera-Gayraud L; Besson R; Berato J; Gilly R
    Arch Mal Appar Dig Mal Nutr; 1965 Nov; 54(11):1174-6. PubMed ID: 5855261
    [No Abstract]   [Full Text] [Related]  

  • 35. INTEGRAL TREATMENT OF BONE METASTASIS.
    COLANDRE TC
    Acta Unio Int Contra Cancrum; 1963; 19():1044-5. PubMed ID: 14059955
    [No Abstract]   [Full Text] [Related]  

  • 36. Surgery of liver metastasis in gynecological cancer - indication and results.
    Kollmar O; Moussavian MR; Richter S; Bolli M; Schilling MK
    Onkologie; 2008 Jul; 31(7):375-9. PubMed ID: 18596384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution to the study of the osseous localiza tions of malignant lymphogranuloma].
    Franco L; Anfossi F; Rossi PL
    Minerva Radiol; 1966 Nov; 11(11):551-8. PubMed ID: 5996290
    [No Abstract]   [Full Text] [Related]  

  • 38. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N; Batraki M; Divgi CR
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
    Hodsman AB
    Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.